Live from ASH 2011: A phase II Study of Ofatumumab in Combination with ICE or DHAP chemotherapy in r - YouTube Memorial Sloan Kettering

Medical oncologist Matthew Matasar discusses the inclusion of OFA in second-line therapy for aggressive or relapsing B-cell non-Hodgkin’s lymphoma.

Live from ASH 2011: A phase II Study of Ofatumumab in Combination with ICE or DHAP chemotherapy in r - YouTube
0 Likes	0 Dislikes
259 views views	9,726 followers
Science & Technology	Upload TimePublished on 27 Dec 2011